NDC 50242-210

Gavreto

Pralsetinib

Gavreto is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Genentech, Inc.. The primary component is Pralsetinib.

• Product ID: 50242-210_05cc6c61-4048-4f99-88e3-f01cb828b21c
• NDC: 50242-210
• Product Type: Human Prescription Drug
• Proprietary Name: Gavreto
• Generic Name: Pralsetinib
• Dosage Form: Capsule
• Route of Administration: ORAL
• Marketing Start Date: 2020-09-04
• Marketing Category: NDA /
• Application Number: NDA213721
• Labeler Name: Genentech, Inc.
• Substance Name: PRALSETINIB
• Active Ingredient Strength: 100 mg/1
• NDC Exclude Flag: N
• Listing Certified Through: 2022-12-31

Packaging

NDC 50242-210-12

1 BOTTLE in 1 CARTON (50242-210-12) > 120 CAPSULE in 1 BOTTLE

• Marketing Start Date: 2021-07-01
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details

NDC Crossover Matching brand name "Gavreto" or generic name "Pralsetinib"

NDC	Brand Name	Generic Name
50242-210	Gavreto	Pralsetinib
72064-210	GAVRETO	pralsetinib